Transaction · 0000914190-26-000129

Crouse Steven C.

Crouse Steven C., PRES, SB, reported a transaction classified as grant at BIO-TECHNE Corp involving 8702.000000 shares for an estimated $0.00. Reported holdings after the transaction were 8702.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APRES, SB
TECHBIO-TECHNE Corp
Trade date
Aug 17, 2026
Filing date
Aug 19, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded8.70k$0.00 per share
Holdings after8.70kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.5%1w ago -0.5%1d ago -0.1%
Returns since7d -0.1%30d -0.1%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0000914190-26-000129
Restricted Stock Units
Transaction date
Aug 17, 2026
Filed Aug 19, 2026, 08:46 PM · 2d delay
Shares
8,702 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
8,702 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President - Diag & Spatial Bi

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    100% vested.

  2. F2

    Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.

  3. F3

    Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.

  4. F4

    Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.

  5. F5

    Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.

  6. F6

    Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.

  7. F7

    Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.

  8. F8

    Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

  9. F9

    Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  10. F10

    794 restricted stock units vest on 5/1/2027.

  11. F11

    600 restricted stock units vest on each of 6/2/2027 and 6/2/2028.

  12. F12

    1,869 restricted stock units vest on 8/15/2027.

  13. F13

    2,177 restricted stock units vest on 8/15/2027, and 2,176 restricted stock units vest on 8/15/2028.

  14. F14

    245 restricted stock units vest on each of 3/2/2027, 3/2/2028 and 3/2/2029.

  15. F15

    2,901 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 2,900 restricted stock units vest on 8/17/2029.

  16. F16

    14,140 restricted stock units vest on 8/17/2029.

Original filing · 0000914190-26-000129
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TECH